Upgrade to SI Premium - Free Trial

Chemours (CC) PT Lowered to $16 at Goldman Sachs

October 9, 2026 9:00 AM
Goldman Sachs analyst Duffy Fischer lowered the price target on Chemours (NYSE: CC) to $16.00 (from $17.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change